PACAP and Maxadilan (PAC1 Agonist) Influence Plaque Progression, Migratory Ability, and Mitochondrial Morphology and Dynamics in Vascular Smooth Muscle Cells

Background: Pituitary adenylate cyclase-activating polypeptide (PACAP) functions as an anti-atherogenic neuropeptide. Maxadilan, a PAC1 receptor agonist, offers atheroprotection by acting downstream of vascular inflammation caused by hypercholesterolemia. This study aims to explore how PACAP and Max...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Julia Brauschke, Lisa-Marie Schütz, Gabriel A. Bonaterra, Ralf Kinscherf, Anja Schwarz
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2026-06-01
Schriftenreihe:	Cells
Schlagworte:	PACAP Maxadilan oxLDL atherosclerosis HCASMC apoptosis
Online-Zugang:	https://www.mdpi.com/2073-4409/15/12/1127
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!